---
title: "Pliant pauses mid-stage trial for lung disease therapy"
date: "2025-02-08 15:33:46"
summary: "Pliant Therapeutics (NASDAQ:PLRX) has paused dosing and enrollments in its Phase 2b trial for its lead asset, bexotegrast, for the lung condition idiopathic pulmonary fibrosis following a data review and recommendations by the study’s safety committee. Shares of the California-based biopharma plunged ~58% in the postmarket trading on Friday after..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/183384636/image_183384636.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Pliant Therapeutics (NASDAQ:[PLRX](https://seekingalpha.com/symbol/PLRX "Pliant Therapeutics, Inc.")) has paused dosing and enrollments in its Phase 2b trial for its lead asset, bexotegrast, for the lung condition idiopathic pulmonary fibrosis following a data review and recommendations by the study’s safety committee.
* Shares of the California-based biopharma plunged ~58% in the postmarket trading on Friday after the announcement.
* According to Pliant’s (NASDAQ:[PLRX](https://seekingalpha.com/symbol/PLRX "Pliant Therapeutics, Inc.")) Q3 2024 earnings release in November, the 52-week global study known as BEACON-IPF was expected to complete enrollments in Q1 2025, with its data anticipated in mid-2026.
* The company said it has voluntarily paused the dosing and further enrollment to understand the reasons behind the recommendation of BEACON-IPF’s independent Data Safety Monitoring Board.
* The study will remain blinded to maintain data integrity, and patients already enrolled will c[ontinue to be part of the study.](https://seekingalpha.com/pr/19995937-pliant-therapeutics-provides-update-on-beacon-ipf-a-phase-2b-3-trial-in-patients-with)

[seekalpha](https://seekingalpha.com/news/4405372-pliant-stock-plunges-trial-pause)
